Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 1, 2003Clinical Transplantation

Individualized T cell monitored administration of ATG versus OKT3 in steroid‐resistant kidney graft rejection

View Full Paper
Ask AI
Bookmark
Share

Authors

KMKarsten MidtvedtNasjonalforeningen for FolkehelsenPFPer FauchaldArctic Research CentreBLBjoern Lien

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Midtvedt et al. (2003) studied this question.

synapsesocial.com/papers/6aa3996e240321efda554fc6https://doi.org/10.1034/j.1399-0012.2003.02105.x
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1HALF DOSE OF OKT3 IS EFFICIENT IN TREATMENT OF STEROID-RESISTANT RENAL ALLOGRAFT REJECTION1996 · 22 citations
  2. 2A RANDOMIZED AND PROSPECTIVE STUDY COMPARING TREATMENT WITH HIGH-DOSE INTRAVENOUS IMMUNOGLOBULIN WITH MONOCLONAL ANTIBODIES FOR RESCUE OF KIDNEY GRAFTS WITH STEROID-RESISTANT REJECTION2001 · 141 citations
  3. 3A randomized prospective study comparing low-dose OKT3 to low-dose ATG for the treatment of acute steroid-resistant rejection episodes in kidney transplant recipients1998 · 58 citations
  4. 4Administration of ATG according to the absolute T lymphocyte count during therapy for steroid-resistant rejection1993 · 42 citations
  5. 5The Banff 97 working classification of renal allograft pathology1999 · 3,059 citations